With any software, the more you use it, the more hacks and shortcuts you discover, and never a truer word has been said when ...

VLOOKUP has been the go-to function for looking up data in Excel for years, but it comes with limitations. You can only ...

Struggling with messy paired columns? Discover step-by-step Power Query techniques to simplify your data and save time on ...

THAT HAPPENS. NEW AT SIX CORTEVA IS SPLITTING UP INTO TWO INDEPENDENT COMPANIES. THE COMPANY SAYS ONE OF THEM WILL BE CALLED NEW CORTEVA, AND IT WILL TAKE OVER THE CROP PROTECTION SIDE OF THE BUSINESS ...

Since their introduction in 1993, PivotTables have remained one of Excel’s most powerful tools for summarizing and analyzing large datasets. With just a few clicks, you can transform raw, unstructured ...

Corteva will separate into two publicly traded companies: New Corteva (crop protection) and SpinCo (seed business). The spin-off is expected to be completed in the second half of 2026 as a tax-free ...

INDIANAPOLIS — Global agriculture technology company Corteva announced Tuesday it will separate into two independent, publicly traded companies. Company leaders say the move will sharpen focus and ...

Corteva, a stronghold seed and pesticide provider in the Indiana agriculture space, will be no more next year as the Indianapolis company on the northwest side rebrands and spawns its seed business.

Bears second-year tackle Theo Benedet always has a tough assignment, not as dificult as last week but a challenge nonetheless. Bears coach Ben Johnson hasn't said Benedet is a starter or backup, or at ...

MIDLAND, Mich. (WNEM) – A global agriculture technology leader plans to split into two independent companies. Corteva made the announcement on Wednesday, Oct. 1 that it plans to split into New Corteva ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced on Tuesday that it plans to explore separating its business into two independent, publicly traded companies. Referred to as “Royalty Management Co” and ...

AnaptysBio plans to split into two publicly traded companies, with one entity taking forward the biopharma’s clinical-stage pipeline and the other overseeing its royalty-based agreements. The crown ...